ATI Inc (ATI) Stock News

Zacks recommends three aerospace-defense equipment stocks with strong growth potential. HEICO Corp. (Rank #1) benefits from sustained demand for aftermarket parts and recent acquisitions, with 33.6% upside potential. ATI Inc. (Rank #1) is driven by strong aerospace and defense demand with record backlog and 29.2% upside. Teledyne Technologies (Rank #2) is supported by rising global defense spending and a $5 billion backlog with 25.2% upside potential.

Rosen Law Firm has filed securities class action lawsuits against AST SpaceMobile, GoDaddy, and Innventure, alleging that defendants made false and misleading statements regarding capital requirements, competitive positioning, and business prospects. Investors who purchased securities during specified class periods are encouraged to join the litigation before upcoming deadlines.

Rosen Law Firm is notifying investors about securities class action lawsuits filed against GoDaddy Inc. and other companies. The GoDaddy lawsuit alleges the company made materially false statements about customer growth strategy and average order size, implementing promotions that contradicted public representations and led to decreased bookings. Investors who purchased stock during specified periods may be eligible for compensation, with an October 20, 2026 deadline to serve as lead plaintiff.

Rosen Law Firm has filed a class action lawsuit against Better Home & Finance Holding Company (BETR) on behalf of investors who purchased securities between March 13, 2026 and May 7, 2026. The lawsuit alleges that defendants made false and misleading statements regarding the company's conversion funnel and $1 billion monthly funded volume target, which were slowing due to macro factors. Investors who wish to serve as lead plaintiff must file by November 20, 2026.

ATI (Allegheny Technologies) fell 3.99% to $186.92, outpacing the S&P 500's 0.22% decline. Despite the recent weakness, the company maintains a Zacks Rank #1 (Strong Buy) rating with strong earnings growth projections of 58.82% EPS increase and 17.87% revenue growth expected for the upcoming quarter.

A Delaware federal court ruled on September 30, 2026, that Liquidia Corporation's lead product Yutrepia inhalation powder infringed two claims of United Therapeutics' patent for treating pulmonary hypertension. The ruling triggered a sharp 57.2% stock price decline from $70.69 to $30.26 per share. Liquidia's CEO stated the company plans to pursue appellate options. A law firm is now investigating potential securities law violations on behalf of stockholders.

Block & Leviton is investigating Millrose Properties for potential securities fraud, alleging the company misled investors about its business dealings with Lennar. A report claimed Millrose purchased approximately $200 million of finished Lennar homes at above retail prices and is renting them at a loss. The stock declined following the report and a subsequent analyst downgrade.

Innovayte, a custody and clearing firm for registered investment advisors, announced the appointment of Fritz Louis-Charles as Chief Operating Officer. Louis-Charles brings over 20 years of financial services experience, including previous roles as COO of Apex Fintech Solutions and leadership positions at JPMorgan Chase and TD Ameritrade. He will oversee enterprise-wide operations and help guide the firm's next growth phase.

Block & Leviton is investigating Lennar Corporation for potentially misleading investors about home delivery numbers in fiscal Q3 2026. The investigation focuses on whether Lennar artificially inflated delivery figures through purchases by its spinoff company Millrose Properties in the final week of the quarter. Lennar's stock fell on October 5, 2026, following an analyst downgrade of Millrose.

Vallourec announces the appointment of Isabelle Quéméneur as Group Chief Digital and Information Officer, effective October 5, 2026. Quéméneur, previously Chief Technology Officer at Danone, joins Vallourec's Executive Committee to lead digital transformation initiatives focused on customer value creation and modernizing team operations in response to cybersecurity and AI challenges.

Vallourec announces the appointment of Isabelle Quéméneur as Director of Digital & IT Systems, effective October 5, 2026. She joins the Executive Committee and brings extensive experience from her previous role as CTO at Danone, along with a background in technology leadership at major international companies including Société Générale, AXA, and Sanofi.

A securities class action lawsuit has been filed against XTI Aerospace, Inc. for allegedly making materially false and misleading statements during April 15 - August 17, 2026. The lawsuit claims senior executives engaged in undisclosed activities that affected disclosure controls and prevented timely earnings report filings. Investors who purchased securities during this period may be eligible for compensation. The deadline to serve as lead plaintiff is October 27, 2026.

Rosen Law Firm has filed a securities class action lawsuit against Tigo Energy, Inc. (NASDAQ: TYGO) on behalf of investors who purchased securities between February 24, 2026 and August 4, 2026. The lawsuit alleges that defendants made materially false and misleading statements regarding revenue projections based on an EG4 partnership that would not provide material revenue until Q4 2026 at the earliest, lacking a reasonable basis for the projections.

A securities class action lawsuit has been filed against DICK'S Sporting Goods, Inc. for allegedly making materially false and misleading statements regarding Foot Locker inventory cleanup, exposure to excess inventory, and promotional pressures in the athletic footwear industry. Investors who purchased DKS common stock between September 8, 2025 and August 24, 2026 may be entitled to compensation. The lead plaintiff deadline is November 3, 2026.

Rosen Law Firm is notifying investors about securities class action lawsuits, including one against Hyliion Holdings Corp. for allegedly making false statements about its VFG Holdings partnership and commercial pipeline credibility. The firm is seeking a lead plaintiff by October 27, 2026, and encourages affected investors to join the litigation.

A securities class action lawsuit has been filed against Hims & Hers Health, Inc. for allegedly making materially false and misleading statements regarding consumer data sharing with third-party advertising platforms, charging for prescriptions before medical consultations, and failing to disclose regulatory scrutiny and potential penalties. The lead plaintiff deadline is November 2, 2026.

Rosen Law Firm is soliciting investors in Beta Bionics, Inc. (NASDAQ: BBNX) who purchased stock between July 30, 2025 and February 24, 2026 to join a securities class action lawsuit. The lawsuit alleges that Beta Bionics made materially false and misleading statements about its iLet Bionic Pancreas insulin pump, concealing that the FDA had raised serious safety concerns including device malfunctions causing dangerously high insulin dosing and thousands of complaints. The lead plaintiff deadline is November 3, 2026.

Law firm Kirby McInerney LLP is investigating potential securities law violations by uniQure N.V. following the release of 48-month data for AMT-130 that showed significantly reduced treatment efficacy (44% disease slowing) compared to previously reported 36-month results (75% slowing). The company had submitted an FDA application based on the stronger 36-month data. uniQure's stock price declined 37.3% on the news, falling from $39.11 to $24.51 per share.

Rosen Law Firm announced securities class action lawsuits against multiple companies. The Simply Good Foods Company faces allegations of making false statements regarding its OWYN acquisition, including undisclosed loss of key personnel, product quality issues, margin erosion, and failure to achieve strategic goals. Similar class actions have been filed against FuelCell Energy and GoDaddy, with important lead plaintiff deadlines approaching.

Rosen Law Firm reminds investors who purchased Innventure, Inc. (NASDAQ: INV) securities between November 17, 2025 and August 13, 2026 of the October 27, 2026 lead plaintiff deadline in an ongoing securities class action. The lawsuit alleges that Innventure made materially false statements regarding Accelsius Holdings LLC's transformative deal with DarkNX, which allegedly had no credible basis, resulting in overstated revenue and cash flow targets for 2026.

Law firm Johnson Fistel is investigating NeoVolta, Inc. following the company's September 23, 2026 financial disclosures that revealed a $13,460 fourth-quarter revenue figure, a $3.9 million provision for credit losses, and a $1.54 million nonoperating credit loss on a note. The stock fell approximately 24% on September 24. The investigation focuses on whether the company adequately disclosed the condition of its residential business, customer receivables, and the timing of when a anticipated transaction with a borrower became unlikely.

Rosen Law Firm is reminding investors in Aardvark Therapeutics, Inc. (AARD) of an October 13, 2026 deadline to join a securities class action lawsuit. The lawsuit alleges that Aardvark made materially false and misleading statements regarding the safety and prospects of its drug ARD-101, causing investor damages when the truth entered the market. The firm is also investigating claims related to Hyliion Holdings Corp. (HYLN) and FLOW cryptocurrency.

Law firm Kirby McInerney LLP is investigating Medline Inc. for potential federal securities law violations following an FDA warning letter in June 2026 detailing significant manufacturing practice violations. The company's stock declined 7.2% on the FDA announcement and another 12.8% in August after Medline disclosed earnings losses from remediation efforts including product recalls.

Rosen Law Firm reminds investors in Datavault AI Inc. (NASDAQ: DVLT) of the October 5, 2026 lead plaintiff deadline in an ongoing securities class action. The lawsuit alleges that defendants made materially false statements regarding overstated corporate partnerships, inflated trading volumes on the Datavault Platform, and undisclosed connections to a convicted felon that caused reputational harm.

Rosen Law Firm is notifying investors of a securities class action lawsuit against HDFC Bank Limited for allegedly making false statements and failing to disclose that the bank camouflaged payments as marketing spend to pay higher interest to a state firm. The lawsuit claims senior management approved these activities, which likely violated regulations and the bank's own policies, resulting in overstated interest income and operating expenses. The lead plaintiff deadline is October 13, 2026.

Rosen Law Firm has filed class action lawsuits against Honeywell Aerospace Inc., Papa John's International Inc., and Tigo Energy Inc. on behalf of investors who purchased securities during specified periods. The lawsuits allege materially false and misleading statements regarding business operations, supply chain issues, and regulatory investigations.

A securities class action lawsuit has been filed against Hyliion Holdings Corp. for allegedly making false and misleading statements regarding its VFG Holdings partnership and commercial pipeline credibility. Investors who purchased HYLN securities between May 12, 2026 and June 23, 2026 may be entitled to compensation. The lead plaintiff deadline is October 27, 2026.

Rosen Law Firm reminds investors of Taboola.com Ltd. (NASDAQ: TBLA) who purchased securities between May 6, 2026 and August 4, 2026 of the October 20, 2026 lead plaintiff deadline in an ongoing securities class action. The lawsuit alleges that Taboola.com made materially false statements regarding its business operations, specifically failing to disclose an increase in low-quality publishers and the need for aggressive exit strategies that would impact earnings.

A securities class action lawsuit has been filed against Park Ha Biological Technology Co., Ltd. for allegedly making materially false statements and failing to disclose a fraudulent stock promotion scheme involving social media misinformation and artificially manipulated trading activity. Investors who purchased securities between December 27, 2024 and July 8, 2025 are encouraged to seek legal counsel before the September 28, 2026 lead plaintiff deadline.

A securities class action lawsuit has been filed against Unicycive Therapeutics, Inc. for allegedly making materially false and misleading statements regarding FDA compliance at its third-party manufacturing vendor. The lawsuit claims the company failed to disclose that it had not inspected the vendor's facility or audited compliance with manufacturing practices, creating undisclosed risks of regulatory delays for its oxylanthanum carbonate drug. Investors who purchased securities between December 29, 2025 and June 29, 2026 may be entitled to compensation. The lead plaintiff deadline is November 2, 2026.